Lamivudine
- Product NDC
- 70518-1084
- 11-digit product format
- 705181084
- Labeler code
- 70518
- Product ID
- 70518-1084_901f7bab-a714-e5dc-e053-2a95a90a7a6c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206974
- Marketing category
- ANDA
- Marketing start
- 2018-03-27
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record